Lipid management in patients with chronic kidney disease
Charles J. Ferro(Queen Elizabeth Hospital Birmingham), Carmine Zoccali(Biogem), Gunnar H. Heine(Agaplesion Markus Hospital), Patrick Rossignol(Inserm), Mehmet Kanbay(Koç University), Francesca Mallamaci(Società Italiana di Nefrologia), Pantelis Sarafidis(Ippokrateio General Hospital of Thessaloniki), Gérard M. London(Unknown), Patrick B. Mark(Queen Elizabeth University Hospital), Alberto Ortíz(Universidad Pontificia de Salamanca), Marianne C. Verhaar(Utrecht University), Raymond Vanholder(Ghent University Hospital), Jolanta Małyszko, José Manuel Valdivielso(Instituto de Investigación Biomédica de Lleida), Ziad Massy(Université de Versailles Saint-Quentin-en-Yvelines), Robert Ekart(University of Maribor)
Cited by 275
Related Papers
Obesity and Kidney Disease: Hidden Consequences of the Epidemic
|American Journal of Nephrology|2017|2.2k
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
|European Heart Journal|2024|1.9k
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study
|The Lancet|2001|1.1k
The Use of Diuretics in Heart Failure with Congestion — A Position Statement from the Heart Failure Association of the European Society of Cardiology
|European Journal of Heart Failure|2019|1.1k
Clinical practice guideline on diagnosis and treatment of hyponatraemia
|Intensive Care Medicine|2014|1k